Synopsis: Alcohol stocks rallied up to 7% after Karnataka’s new liquor policy eased pricing controls and reduced slabs from 16 to 8. The state, which contributes around 15% of India’s IMFL market, also introduced brewery tourism, boosting investor optimism about...
Synopsis: A tyre stock with a market cap of ₹27,884 crore is gaining attention after a brokerage assigned a ‘Buy’ rating with a target price of ₹600, implying nearly 37% upside from ₹439. Strong industry demand, capacity expansion worth ₹58 billion, and rising...
Synopsis:- A defence stock surged nearly 11% after securing a ₹68.05 crore order from Hindustan Aeronautics for airborne antennas and power supplies. Despite recent operational pressure, the company maintains a strong order book of about ₹2,582 crore and continues...
Synopsis:- A global brokerage maintained a ‘Neutral’ rating with a target price of ₹2,275, implying about 2% downside from ₹2,316. The company expects US business to cross $1 billion, plans five biosimilar launches in five years, while OPM improved from 24% to 32%. ...
Synopsis:- Prominent investors executed bulk deals in select stocks, signalling portfolio reshuffling. One transaction involved the sale of 20.5 lakh and 22.48 lakh shares worth about ₹357.66 crore, while another saw 2.36 lakh shares each sold at ₹375 per share,...
Synopsis: Shares of an e-commerce electronics platform rose nearly 4% after the board approved a 1:10 bonus share issue, with March 10, 2026, set as the record date. The stock traded around ₹920, while operating profit improved from ₹3.74 crore to ₹8.05 crore over the...
Synopsis: Shares of a leading power exchange rose about 2% after reporting strong February performance, with electricity traded volume reaching 12,550 MU, up 30.4% YoY. Day-Ahead Market volume stood at 6,588 MU, while Real-Time Market surged 51.7% to 4,379 MU,...
Synopsis: Several stocks, including Vedant Fashions, Afcons Infrastructure, and Firstsource Solutions, are trading in the oversold zone with RSI between 17.50 and 26.97, signalling potential short-term price rebounds. The Relative Strength Index (RSI) is a widely used...
Synopsis: Shares of a major pharma player gained attention after its subsidiary launched Pomalidomide Capsules in the U.S., targeting a $3.3 billion oncology market. Meanwhile, new MIP rules on Pen-G, 6-APA, and Amoxicillin could benefit domestic manufacturers with...
Synopsis:-Several bulk deals were recorded as investors adjusted their holdings in select stocks. One investor acquired 51.25 lakh shares worth ₹11.95 crore, while another transaction involved a sale of 8.28 lakh shares valued at ₹70.18 crore. Meanwhile, smaller...
